Sen­ate com­mit­tee ad­vances bill tar­get­ing Chi­nese man­u­fac­tur­ers as BIO faces at­tack for back­ing WuXi

A Sen­ate com­mit­tee on Wednes­day moved a con­tentious bill for­ward that would pro­hib­it many bio­phar­ma com­pa­nies from us­ing cer­tain for­eign man­u­fac­tur­ing and tri­al ser­vice providers …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER